HOW WE MEASURE BUSINESS PERFORMANCE AND POTENTIAL

Know exactly where your pharmacy stands.

Your data. Industry data. Live benchmarks. Every day.

Making the right decisions hinges on getting the right information.

The Pharmacy Bureau Atlas Dashboard gives every pharmacy owner a clear, evidence-based picture of their business across all four income streams — set against the benchmarks that matter — so every coaching conversation starts with facts, not guesses.

Most pharmacy owners know their script volume. Very few know their Patient Loyalty Score, their GP$ per script against the national panel, or what their top ten prescribers are worth to their annual gross profit. That gap is exactly where Pharmacy Bureau works.

483

Pharmacies in the Guild Digest 2025 benchmark survey

5000+

Pharmacies in the Pharma|Ledger national panel

8

Dashboard tabs covering every part of your pharmacy

4

Income streams — Dispensary, Services, MAS, Front of Practice

Every income stream. Every key metric. One tool.

The Atlas dashboard is built around the four income streams that define a modern Australian community pharmacy. Each stream has its own tab — with your inputs, prior period comparisons, budget targets, and published benchmarks side by side.

Dispensary

Track your largest income stream, daily, weekly and monthly. Covers script volumes, GP$ per script, 60-Day Dispensing impact, GLP-1 tracking, and the operational GP% measure that strips out HVLM distortion for a clean trend read.
  • GP$ per script $14.20 panel median
  • Rx GP% ex-HVLM 37.1% panel median
  • 60DD packs per script 1.21 baseline 
  • GLP-1 scripts — % of dispensary turnover & GP$
  • TSI (Transaction-Script Index) 1.92x panel median
  • Generic substitution % 74.5% panel median

Professional Services

The highest-leverage income stream for most pharmacies — near-100% GP contribution on every service delivered. The dashboard tracks both the national average and the innovator benchmark.
  • Services income — national average $111,918 pa — Guild Digest 2025
  • Services income — innovator benchmark $158,076 pa — 
  • Services income per patient $1.23 (innovator) vs $0.47–$0.56 national avg
  • 8CPA services — community DAA patients 100 patient target
  • Pharmacists trained in services 100% target
  • Pharmacist-recommended services at script-out 20–25% range

Minor Ailments

A net-new income stream as scope of practice expands across Australia. The dashboard tracks protocol availability, consult conversion rates, and pharmacist training readiness.
  • MAS protocols available Target: 25+
  • MAS consults — % of patients seen 10% target
  • MAS consults — % of consult room engagements 15% target
  • Expanded scope programs 19 in due course
  • Pharmacists trained in MAS 100% target
  • Patient-funded services growth year-on-year

Front of Practice

Formerly known as OTC or retail — this is the income stream most pharmacy owners under-manage. The dashboard tracks stock intensity, shelf space allocation, average retail sale per patient, and GP$ per linear metre.
  • Average retail sale per patient $18.18 benchmark
  • OTC GP% 31.4% panel median 
  • Stock intensity (stock at cost per m²) $1,300 target 
  • GP$ per shelf linear metre $2,522 top performers 
  • GMROS (GP$ per total rented space) $9,744 benchmark 
  • Retail category tiers — Blockbuster / Health / Sundry sales

Industry data. Named sources. No guesswork.

Every benchmark in the dashboard is sourced, cited, and current. We don't use rules of thumb — we use the actual published figures from the surveys and panel reports that cover Australian community pharmacy.

Benchmark sources

Guild Digest 2025 — FY2023-24, n=483 pharmacies | Pharma|Ledger National Panel — 5,000+ pharmacies

Now benchmarked against 5,000+ Australian pharmacies

Pharmacy Bureau coaching clients now have access to Pharma|Ledger reports — a national panel drawing on POS till-level and dispense script-level data from over 5,000 community pharmacies, refreshed on a rolling 12-month basis. This introduces two genuinely new dimensions: patient loyalty and leakage risk, and prescriber concentration and stability risk.

Patient Loyalty Score

The share of each patient's total scripts that your pharmacy fills — not whether they came back, but how much of their business you actually capture.

Leaked Rx Dollars

The Rx spend by your active patients that went to a competitor pharmacy. A dollar figure you can act on.

Prescriber Concentration Risk

What happens to your revenue if your top 10 prescribers move, retire, or shift their patients elsewhere? Now you can see the exposure clearly, before it becomes a crisis.

Stock Ageing & Days on Hand

Pharma|Ledger national panel median: 45 days on hand and less than 7% of inventory in the 120+ day bucket. Where does your pharmacy sit?

"Most pharmacy owners know their script volume. Very few know their Patient Loyalty Score, their GP$ per script against the national panel, or what their top ten prescribers are worth to their annual gross profit. That gap is where Pharmacy Bureau works."

- Mal Scrymgeour — Founder & Managing Director, Pharmacy Bureau

The dashboard is the conversation.

The Atlas dashboard is not a report you read once and file. It's the tool used in every coaching session to identify what's working, what isn't, and what to do next.

You’ve worked hard to get here. Let’s make it count.